Chia Tai Tianqing Pharmaceutical (guangzhou) Co., Ltd.

This is an early safety study for a new inhaler called TQC3302, which is being developed for Chronic Obstructive Pulmonary Disease (COPD). Researchers are testing it in 57 healthy adults to see how safe it is, how well it is tolerated, and how the body processes the drug. The mai…